PI
-
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
Apperley, J. F., Milojkovic, D., Cross, N. C. P., Hjorth-Hansen, H., Hochhaus, A., Kantarjian, H., Lipton, J. H., Malhotra, H., Niederwieser, D., Radich, J., Rousselot, P., Saussele, S., Schiffer, C. A., Silver, R., Soverini, S., Stenke, L., Turkina, A., Casado, L. F., Castagnetti, F. & Cervantes, F. & 18 others, , Aug 2025, In: Leukemia. 39, 8, p. 1797-1813 17 p.Research output: Contribution to journal › Review article › Academic › peer-review
-
Conditional progression-free survival in patients with metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with first-line ribociclib and endocrine therapy: real-world data from the RIBANNA study
Decker, T., Brucker, C., Engel, A., Fasching, P. A., Göhler, T., Jackisch, C., Janssen, J., Köhler, A., Lüdtke-Heckenkamp, K., Lüftner, D., Marmé, F., van Mackelenbergh, M., Rautenberg, B., Schmidt, M., Weide, R., Wimberger, P., Kisseleff, E., Pfister, C., Roos, C. & Wilhelm, N. & 1 others, , 1 Jun 2025, In: ESMO open. 10, 6, 105105.Research output: Contribution to journal › Article › Academic › peer-review
-
Patient-reported toxicity symptoms during tyrosine kinase inhibitor treatment in chronic myeloid leukemia: a systematic review and meta-analysis
Smit, Y., Scheuter, P., Lange, M. P. M., Janssen, J. J. W. M., Posthuma, E. F. M., Bekker, C. L., Hermens, R. P. M. G. & Blijlevens, N. M. A., 1 May 2025, In: Supportive care in cancer. 33, 5, 446.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications